Psychopharmacological Treatment of ADHD in Adults Aged 50

Psychopharmacological Treatment of ADHD in Adults Aged 50

Objective: To study pharmacotherapy in adults aged 50+ with ADHD. Method: A survey was administered to adults with ADHD ( greater than or equal to 50 years old). Participants on medication for ADHD were compared with those not on medications. Results: Mean age of participants was 55.8 years, and mea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of attention disorders 2015-05, Vol.19 (5), p.380-389
Hauptverfasser: Lensing, Michael B, Zeiner, Pal, Sandvik, Leiv, Opjordsmoen, Stein
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 389
container_issue 5
container_start_page 380
container_title Journal of attention disorders
container_volume 19
creator Lensing, Michael B
Zeiner, Pal
Sandvik, Leiv
Opjordsmoen, Stein
description Objective: To study pharmacotherapy in adults aged 50+ with ADHD. Method: A survey was administered to adults with ADHD ( greater than or equal to 50 years old). Participants on medication for ADHD were compared with those not on medications. Results: Mean age of participants was 55.8 years, and mean age when diagnosed with ADHD was 50.3 years. Ninety-five participants (63.8%) reported current psychopharmacological treatment for ADHD, 36 (24.2%) had stopped psychopharmacological treatment, and 18 (12.0%) were psychopharmacological treatment naive for ADHD. Those currently being treated psychopharmacologically for ADHD reported significantly improved attention relative to the two nonmedicated groups (p < .01). Among examined sample characteristics (including current psychopharmacological treatment for ADHD), employment was associated with a better outcome (odds ratio = 3.3, p = .006). Conclusion: The majority of adults aged 50+ with ADHD reported regular pharmacotherapy for ADHD. Participants currently receiving psychopharmacological treatment for ADHD reported better attention than those not receiving pharmacotherapy. Employment was associated with more favorable outcomes.
doi_str_mv 10.1177/1087054714527342
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808715409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808715409</sourcerecordid><originalsourceid>FETCH-LOGICAL-c809-b978dcd2d110a34ac2dfb29a3d650c97f34c0d27039b369be06a95dd6747fba03</originalsourceid><addsrcrecordid>eNotjz1PwzAUAD2ARCnsjB5ZAs9fefEYtUCRKsGQvXqxnTbIiUucDvx7qOh00g0nHWMPAp6EQHwWUCEYjUIbiUrLK7Y4q-Lsbthtzl8AChHlgtnP_OMO6XigaSCXYtr3jiJvpkDzEMaZp47X682a9yOv_SnOmdf74LmBO3bdUczh_sIla15fmtWm2H68va_qbeEqsEVrsfLOSy8EkNLkpO9aaUn50oCz2CntwEsEZVtV2jZASdZ4X6LGriVQS_b4nz1O6fsU8rwb-uxCjDSGdMo7Uf2dCaPBql8V-0dN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808715409</pqid></control><display><type>article</type><title>Psychopharmacological Treatment of ADHD in Adults Aged 50</title><source>SAGE Complete</source><creator>Lensing, Michael B ; Zeiner, Pal ; Sandvik, Leiv ; Opjordsmoen, Stein</creator><creatorcontrib>Lensing, Michael B ; Zeiner, Pal ; Sandvik, Leiv ; Opjordsmoen, Stein</creatorcontrib><description>Objective: To study pharmacotherapy in adults aged 50+ with ADHD. Method: A survey was administered to adults with ADHD ( greater than or equal to 50 years old). Participants on medication for ADHD were compared with those not on medications. Results: Mean age of participants was 55.8 years, and mean age when diagnosed with ADHD was 50.3 years. Ninety-five participants (63.8%) reported current psychopharmacological treatment for ADHD, 36 (24.2%) had stopped psychopharmacological treatment, and 18 (12.0%) were psychopharmacological treatment naive for ADHD. Those currently being treated psychopharmacologically for ADHD reported significantly improved attention relative to the two nonmedicated groups (p &lt; .01). Among examined sample characteristics (including current psychopharmacological treatment for ADHD), employment was associated with a better outcome (odds ratio = 3.3, p = .006). Conclusion: The majority of adults aged 50+ with ADHD reported regular pharmacotherapy for ADHD. Participants currently receiving psychopharmacological treatment for ADHD reported better attention than those not receiving pharmacotherapy. Employment was associated with more favorable outcomes.</description><identifier>ISSN: 1087-0547</identifier><identifier>DOI: 10.1177/1087054714527342</identifier><language>eng</language><ispartof>Journal of attention disorders, 2015-05, Vol.19 (5), p.380-389</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c809-b978dcd2d110a34ac2dfb29a3d650c97f34c0d27039b369be06a95dd6747fba03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Lensing, Michael B</creatorcontrib><creatorcontrib>Zeiner, Pal</creatorcontrib><creatorcontrib>Sandvik, Leiv</creatorcontrib><creatorcontrib>Opjordsmoen, Stein</creatorcontrib><title>Psychopharmacological Treatment of ADHD in Adults Aged 50</title><title>Journal of attention disorders</title><description>Objective: To study pharmacotherapy in adults aged 50+ with ADHD. Method: A survey was administered to adults with ADHD ( greater than or equal to 50 years old). Participants on medication for ADHD were compared with those not on medications. Results: Mean age of participants was 55.8 years, and mean age when diagnosed with ADHD was 50.3 years. Ninety-five participants (63.8%) reported current psychopharmacological treatment for ADHD, 36 (24.2%) had stopped psychopharmacological treatment, and 18 (12.0%) were psychopharmacological treatment naive for ADHD. Those currently being treated psychopharmacologically for ADHD reported significantly improved attention relative to the two nonmedicated groups (p &lt; .01). Among examined sample characteristics (including current psychopharmacological treatment for ADHD), employment was associated with a better outcome (odds ratio = 3.3, p = .006). Conclusion: The majority of adults aged 50+ with ADHD reported regular pharmacotherapy for ADHD. Participants currently receiving psychopharmacological treatment for ADHD reported better attention than those not receiving pharmacotherapy. Employment was associated with more favorable outcomes.</description><issn>1087-0547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNotjz1PwzAUAD2ARCnsjB5ZAs9fefEYtUCRKsGQvXqxnTbIiUucDvx7qOh00g0nHWMPAp6EQHwWUCEYjUIbiUrLK7Y4q-Lsbthtzl8AChHlgtnP_OMO6XigaSCXYtr3jiJvpkDzEMaZp47X682a9yOv_SnOmdf74LmBO3bdUczh_sIla15fmtWm2H68va_qbeEqsEVrsfLOSy8EkNLkpO9aaUn50oCz2CntwEsEZVtV2jZASdZ4X6LGriVQS_b4nz1O6fsU8rwb-uxCjDSGdMo7Uf2dCaPBql8V-0dN</recordid><startdate>20150501</startdate><enddate>20150501</enddate><creator>Lensing, Michael B</creator><creator>Zeiner, Pal</creator><creator>Sandvik, Leiv</creator><creator>Opjordsmoen, Stein</creator><scope>7TK</scope></search><sort><creationdate>20150501</creationdate><title>Psychopharmacological Treatment of ADHD in Adults Aged 50</title><author>Lensing, Michael B ; Zeiner, Pal ; Sandvik, Leiv ; Opjordsmoen, Stein</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c809-b978dcd2d110a34ac2dfb29a3d650c97f34c0d27039b369be06a95dd6747fba03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lensing, Michael B</creatorcontrib><creatorcontrib>Zeiner, Pal</creatorcontrib><creatorcontrib>Sandvik, Leiv</creatorcontrib><creatorcontrib>Opjordsmoen, Stein</creatorcontrib><collection>Neurosciences Abstracts</collection><jtitle>Journal of attention disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lensing, Michael B</au><au>Zeiner, Pal</au><au>Sandvik, Leiv</au><au>Opjordsmoen, Stein</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psychopharmacological Treatment of ADHD in Adults Aged 50</atitle><jtitle>Journal of attention disorders</jtitle><date>2015-05-01</date><risdate>2015</risdate><volume>19</volume><issue>5</issue><spage>380</spage><epage>389</epage><pages>380-389</pages><issn>1087-0547</issn><abstract>Objective: To study pharmacotherapy in adults aged 50+ with ADHD. Method: A survey was administered to adults with ADHD ( greater than or equal to 50 years old). Participants on medication for ADHD were compared with those not on medications. Results: Mean age of participants was 55.8 years, and mean age when diagnosed with ADHD was 50.3 years. Ninety-five participants (63.8%) reported current psychopharmacological treatment for ADHD, 36 (24.2%) had stopped psychopharmacological treatment, and 18 (12.0%) were psychopharmacological treatment naive for ADHD. Those currently being treated psychopharmacologically for ADHD reported significantly improved attention relative to the two nonmedicated groups (p &lt; .01). Among examined sample characteristics (including current psychopharmacological treatment for ADHD), employment was associated with a better outcome (odds ratio = 3.3, p = .006). Conclusion: The majority of adults aged 50+ with ADHD reported regular pharmacotherapy for ADHD. Participants currently receiving psychopharmacological treatment for ADHD reported better attention than those not receiving pharmacotherapy. Employment was associated with more favorable outcomes.</abstract><doi>10.1177/1087054714527342</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1087-0547
ispartof Journal of attention disorders, 2015-05, Vol.19 (5), p.380-389
issn 1087-0547
language eng
recordid cdi_proquest_miscellaneous_1808715409
source SAGE Complete
title Psychopharmacological Treatment of ADHD in Adults Aged 50
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T10%3A12%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psychopharmacological%20Treatment%20of%20ADHD%20in%20Adults%20Aged%2050&rft.jtitle=Journal%20of%20attention%20disorders&rft.au=Lensing,%20Michael%20B&rft.date=2015-05-01&rft.volume=19&rft.issue=5&rft.spage=380&rft.epage=389&rft.pages=380-389&rft.issn=1087-0547&rft_id=info:doi/10.1177/1087054714527342&rft_dat=%3Cproquest%3E1808715409%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1808715409&rft_id=info:pmid/&rfr_iscdi=true